ART3 Antibody

What is ART3 and what cellular functions does it regulate?

ART3 (ADP-ribosyltransferase 3) is a member of the mono-ADP-ribosyltransferase family that plays significant roles in cellular signaling pathways. Research indicates that ART3 is involved in regulating cell proliferation, invasion, and survival mechanisms in various cell types. Notably, ART3 has been found to activate critical signaling pathways including Akt and ERK in cancer cells, suggesting its role in modulating cellular growth and apoptotic resistance . Its expression pattern is particularly notable in testicular tissue across multiple species, as well as showing significant upregulation in certain cancer subtypes, particularly triple-negative breast cancer (TNBC) .

What applications are most suitable for ART3 antibody use in research?

ART3 antibodies have been validated for multiple experimental applications with varying optimal dilutions:

Researchers should note that optimal dilutions may vary depending on specific tissue types and experimental conditions. ART3 antibody has demonstrated consistent reactivity with human, mouse, and rat samples, making it versatile for cross-species investigations .

What protocols are recommended for ART3 antibody storage and handling?

For optimal performance and stability:

• Store the antibody at -20°C in its original buffer (PBS with 0.02% sodium azide and 50% glycerol, pH 7.3)

• The antibody remains stable for approximately one year after shipment when properly stored

• For -20°C storage, aliquoting is generally unnecessary for standard research quantities

• Note that certain formulations (20μl sizes) contain 0.1% BSA, which may affect certain applications

• Avoid repeated freeze-thaw cycles to maintain antibody performance

How should I validate the specificity of an ART3 antibody for my research?

Comprehensive validation strategies should include:

• Positive and negative control tissues: Testicular tissue from human, rat, or mouse has been confirmed as positive controls for ART3 detection, showing consistent expression patterns .

• Knockdown/knockout validation: Compare antibody reactivity in wild-type versus ART3-silenced samples. Published research has utilized siRNA-mediated knockdown of ART3 in cell lines such as MDA-MB-231 and BT549 to confirm antibody specificity .

• Molecular weight verification: The expected molecular weight range for ART3 is 38-47 kDa. The calculated molecular weight based on amino acid sequence is 44 kDa (389 amino acids), though observed weights may vary slightly due to post-translational modifications .

• Cross-reactivity assessment: When working with novel cell types or species not previously validated, perform parallel experiments with multiple antibodies targeting different epitopes of ART3.

What are the optimal experimental conditions for detecting ART3 in Western blotting?

For optimal Western blot detection of ART3:

• Sample preparation: For tissue samples, particularly testicular tissue, use standard RIPA or NP-40 based lysis buffers with protease inhibitors.

• Loading concentration: Load 20-40 μg of total protein per lane for standard cell lysates; optimization may be required for specific samples.

• Antibody dilution range: Start with 1:1000 dilution in 5% BSA or non-fat milk, adjusting within the 1:500-1:2000 range based on signal strength and background .

• Incubation conditions: Overnight incubation at 4°C typically produces optimal signal-to-noise ratio.

• Detection system: Both chemiluminescence and fluorescence-based secondary detection systems are compatible, with choice depending on required sensitivity.

How can ART3 antibodies be utilized in cancer research, particularly for triple-negative breast cancer studies?

ART3 has emerged as a significant marker in triple-negative breast cancer (TNBC) research, with multiple applications:

• Expression profiling: ART3 protein is significantly overexpressed in TNBC compared to non-TNBC tissues, making antibody-based detection valuable for subtyping and potential prognostic applications .

• Mechanistic pathway studies: Research has demonstrated that ART3 activates both Akt and ERK signaling pathways in TNBC cells. Co-immunoprecipitation experiments using ART3 antibodies can help elucidate protein-protein interactions within these pathways .

• Functional studies: Combining ART3 antibody detection with overexpression or knockdown experiments provides powerful insights into ART3's role in cancer cell proliferation, invasion, and apoptosis resistance .

• In vivo tumor models: Immunohistochemical analysis of xenograft tumors using ART3 antibodies has demonstrated correlation between ART3 expression levels and tumor growth rates, as well as activation status of downstream signaling molecules (phosphorylated AKT and ERK1) .

What are the known technical challenges in ART3 antibody-based research and how can they be addressed?

Several technical challenges require attention when working with ART3 antibodies:

• Isoform specificity: ART3 may exist in variant forms with different molecular weights or post-translational modifications. Researchers should confirm which isoforms are recognized by their specific antibody.

• Background in specific tissues: Some tissues may show non-specific binding. This can be mitigated by:

  • Increasing blocking duration and concentration (5-10% BSA or milk)

  • Optimizing primary antibody dilution (testing a range within 1:500-1:2000)

  • Implementing additional washing steps with increased Tween-20 concentration (0.1-0.2%)

• Cross-reactivity with related ART family proteins: The ART family contains multiple members with sequence homology. When interpreting results, consider potential cross-reactivity with other ART family members.

• Fixation sensitivity in immunohistochemistry: Formalin fixation can mask ART3 epitopes. Antigen retrieval optimization (testing both citrate and EDTA-based methods at varying pH levels) is recommended for immunohistochemical applications.

How do I interpret conflicting results between ART3 protein detection and mRNA expression data?

Discrepancies between protein and mRNA levels may arise from several factors:

• Post-transcriptional regulation: ART3 may be subject to microRNA-mediated regulation or RNA stability mechanisms that create discordance between transcript and protein levels.

• Post-translational modifications: Protein stability, degradation rates, and detection by antibodies can be affected by phosphorylation, glycosylation, or other modifications.

• Technical methodology differences: Consider differences in sensitivity between detection methods. Western blotting with ART3 antibodies has a different dynamic range than qRT-PCR for mRNA quantification.

• Antibody epitope accessibility: Certain cellular conditions or protein conformations may mask antibody epitopes without affecting protein abundance.

To resolve such discrepancies:

• Employ multiple antibodies targeting different ART3 epitopes

• Combine protein and mRNA detection within the same samples

• Use orthogonal approaches such as mass spectrometry to confirm protein expression levels

• Consider immunoprecipitation followed by Western blotting to enrich for ART3 protein

What controls are essential when using ART3 antibodies in functional studies of cancer cells?

For robust experimental design in cancer research applications:

• Genetic manipulation controls:

  • Include both ART3 overexpression and knockdown conditions

  • Use vector-only controls for overexpression studies

  • Employ non-targeting siRNA/shRNA controls for knockdown studies

• Tissue type controls:

  • For breast cancer studies, include both TNBC and non-TNBC cell lines

  • Testicular tissue or testis-derived cell lines can serve as positive controls for ART3 expression

• Signaling pathway validation:

  • Monitor both ART3 levels and downstream effectors (phosphorylated ERK, AKT)

  • Include pathway inhibitor controls (MEK inhibitors, PI3K inhibitors) to confirm specificity of ART3-mediated effects

• Functional readout controls:

  • For proliferation studies: include positive controls (growth factor stimulation) and negative controls (serum starvation)

  • For invasion assays: include both highly invasive and non-invasive control cell lines

How can I optimize immunohistochemical detection of ART3 in tissue microarrays?

For optimal immunohistochemical detection of ART3 in tissue microarrays:

• Antigen retrieval optimization:

  • Test both heat-induced epitope retrieval methods (citrate buffer pH 6.0 and EDTA buffer pH 9.0)

  • Optimize retrieval duration (10-30 minutes)

  • Compare microwave, pressure cooker, and water bath methods

• Antibody titration:

  • Begin with 1:100 dilution and test a range (1:50 to 1:500)

  • Include positive control tissue sections (testicular tissue) on each slide

• Signal amplification considerations:

  • For low-abundance detection, consider tyramide signal amplification systems

  • Evaluate polymer-based detection systems versus avidin-biotin methods

• Counterstaining optimization:

  • Adjust hematoxylin intensity to maintain nuclear detail without obscuring cytoplasmic ART3 staining

  • Consider dual immunofluorescence with markers of interest (e.g., cytokeratins for epithelial cells)

• Quantification methods:

  • Define clear scoring criteria (percentage positive cells, intensity scale)

  • Consider digital image analysis for consistent quantification across samples

What methodological approaches can improve detection of ART3 in low-expressing samples?

For enhanced sensitivity in detecting low ART3 expression:

• Sample enrichment techniques:

  • Immunoprecipitation before Western blotting

  • Subcellular fractionation to concentrate compartments with highest ART3 expression

• Signal amplification in Western blotting:

  • Extended exposure times with high-sensitivity ECL substrates

  • Use of signal enhancers such as sodium orthovanadate in blocking buffers

  • Consideration of fluorescence-based secondary antibodies with infrared detection systems

• mRNA analysis as complementary approach:

  • qRT-PCR for ART3 transcript detection

  • RNAscope or similar in situ hybridization techniques for spatial localization

• Loading optimization:

  • Increasing protein load (50-100 μg) for Western blotting

  • Extended antibody incubation times (24-48 hours at 4°C)

How does ART3 expression correlate with clinical outcomes in cancer patients?

Research on ART3 expression and clinical outcomes has revealed:

• Prognostic significance in breast cancer:

  • ART3 mRNA overexpression correlates with shorter survival for breast cancer patients

  • ART3 protein levels are significantly associated with the triple-negative/basal-like breast cancer phenotype, which typically has poorer outcomes

• Functional implications:

  • ART3-induced cell growth and invasion through ERK and AKT pathway activation suggests it may contribute to more aggressive disease

  • Reduced apoptosis in ART3-overexpressing cells indicates potential therapy resistance mechanisms

• Potential as therapeutic target:

  • Knockdown of ART3 inhibits proliferation and invasion of breast cancer cells

  • Xenograft models show enhanced tumor growth with ART3 overexpression

Researchers investigating clinical correlations should consider:

• Multivariate analysis including established prognostic factors

• Stratification by molecular subtypes

• Correlation with treatment response data

• Integration of genomic and proteomic data sets

What is known about the interaction between ART3 and other members of the ADP-ribosyltransferase family in cellular function?

Current understanding of ART3's interactions with other ADP-ribosyltransferase family members:

• Functional redundancy vs. specificity:

  • ART3 belongs to a family of ecto-ADP-ribosyltransferases with partially overlapping functions

  • Unlike some ARTs, ART3's role in DNA repair and genome stabilization may connect to PARP functions

• Substrate specificity:

  • Different ART family members have distinct substrate preferences

  • Research into ART3-specific substrates is still developing

  • Potential cross-talk between ART3 and PARP-mediated ADP-ribosylation pathways

• Physiological vs. pathological roles:

  • Normal expression of ART3 in testicular tissue suggests tissue-specific functions

  • Pathological overexpression in cancer contexts indicates context-dependent roles

  • Interactions between different ART family members may vary between normal and disease states

Future research directions should include:

• Co-immunoprecipitation studies with ART3 antibodies to identify protein interactors

• Comparative knockdown studies of multiple ART family members

• Substrate identification through proteomic approaches

• Investigation of redundancy or compensation between ART family members

What are common causes of non-specific bands when using ART3 antibodies in Western blotting?

Several factors can contribute to non-specific bands:

• Cross-reactivity with related proteins:

  • Other ART family members may share epitope homology

  • Use ART3 knockout/knockdown controls to identify specific bands

• Sample preparation issues:

  • Incomplete protein denaturation can cause aggregation and unexpected bands

  • Protein degradation may produce fragments detected by the antibody

  • Ensure fresh sample preparation with appropriate protease inhibitors

• Antibody concentration factors:

  • Excessive antibody concentration increases non-specific binding

  • Try more stringent dilutions (1:1000-1:2000) to reduce background

• Blocking and washing optimization:

  • Insufficient blocking leads to non-specific binding

  • Extend blocking time (1-2 hours) and increase blocking agent concentration (5%)

  • Add 0.1-0.2% Tween-20 to wash buffers and extend washing steps

• Secondary antibody issues:

  • Cross-reactivity of secondary antibodies

  • Consider using more specific secondary antibodies or different detection systems

How can I distinguish between technical artifacts and genuine ART3 expression patterns in immunohistochemistry?

To differentiate genuine staining from artifacts:

• Pattern analysis:

  • Genuine ART3 staining should show subcellular localization consistent with its biological function

  • Edge artifacts often show increased intensity at tissue borders

  • Non-specific nuclear staining may indicate antibody concentration issues

• Multiple antibody validation:

  • Compare staining patterns using antibodies targeting different ART3 epitopes

  • Consistent patterns across different antibodies suggest specific detection

• Correlation with other detection methods:

  • Validate IHC findings with in situ hybridization for ART3 mRNA

  • Compare with Western blotting results from the same tissue types

• Blocking peptide controls:

  • Pre-incubation of the antibody with blocking peptides should eliminate specific staining

  • Persistent staining after peptide blocking suggests non-specific binding

• Technical control procedures:

  • Include no-primary-antibody controls

  • Use isotype-matched control antibodies

  • Compare with tissues known to be negative for ART3 expression

What is known about ART3 function in normal physiology and non-cancer disease states?

Current understanding of ART3 in normal physiological contexts:

• Tissue-specific expression patterns:

  • Highest expression in testicular tissue across human, mouse, and rat models

  • Detected in multiple tissues but with variable expression levels

• Potential reproductive biology roles:

  • Given its enrichment in testicular tissue, ART3 may have specialized functions in reproduction

  • Research on infertility models may benefit from ART3 antibody applications

• Signaling pathway involvement:

  • ART3 activates ERK and AKT pathways, suggesting potential roles in normal growth and development processes

  • These pathways are crucial in multiple physiological contexts beyond cancer

• ADP-ribosylation in normal cellular function:

  • ADP-ribosylation modifies protein function and is involved in numerous cellular processes

  • ART3's enzymatic activity may regulate specific cellular substrates in normal tissues

How can multiplexed immunofluorescence with ART3 antibodies enhance our understanding of its cellular functions?

Multiplexed immunofluorescence approaches offer several advantages:

• Co-localization analysis:

  • Combining ART3 antibodies with markers for cellular compartments (ER, Golgi, nucleus) can reveal subcellular localization

  • Co-staining with signaling pathway components (phospho-ERK, phospho-AKT) can demonstrate functional associations

• Cell-type specific expression:

  • In heterogeneous tissues, multiplexing with cell type-specific markers clarifies which cells express ART3

  • Particularly valuable in cancer microenvironment studies to distinguish tumor from stromal expression

• Technical considerations:

  • Primary antibody host species must be considered to avoid cross-reactivity

  • Sequential staining protocols may be required if antibodies are from the same species

  • Spectral unmixing may be necessary with multiple fluorophores

• Quantitative analysis approaches:

  • Digital image analysis of multiplexed immunofluorescence enables quantitative assessment of co-expression

  • Single-cell analysis of expression levels across different cell populations

Researchers should optimize:

• Antibody dilutions for each marker in the multiplexed panel

• Antigen retrieval conditions compatible with all antibodies

• Detection systems with minimal spectral overlap

• Image acquisition settings to prevent fluorophore bleed-through